1.Chen-Yoshikawa TF, Sugimoto S, Shiraishi T, Minami M, Matsuda Y, Chida M, Maeda S, Aoyama A, Okada Y, Okumura M, Iwasaki A, Miyoshi S, Oto T, Date H. Prognostic factors in lung transplantation after hematopoietic stem cell transplantation. Transplantation. 2018 Jan;102(1):154-161. doi: 10.1097/TP.0000000000001886.

2.Sagawa M, Oizumi H, Suzuki H, Uramoto H, Usuda K, Sakurada A, Chida M, Shiono S, Abe J, Hasumi T, Sato M, Sato N, Shibuya J, Deguchi H, Okada Y. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity. Eur J Cardiothorac Surg. 2018 Apr 1;53(4):849-856. doi: 10.1093/ejcts/ezx418.

3.Kasajima A, Ishikawa Y, Iwata A, Steiger K, Oka N, Ishida H, Sakurada A, Suzuki H, Kameya T, Konukiewitz B, Klöppel G, Okada Y, Sasano H, Weichert W. Inflammation and PD-L1 expression in pulmonary neuroendocrine tumors. Endocr Relat Cancer. 2018 Mar;25(3):339-350. doi: 10.1530/ERC-17-0427. Epub 2018 Jan 11.

4.Saito R, Miki Y, Ishida N, Inoue C, Kobayashi M, Hata S, Yamada-Okabe H, Okada Y, Sasano H. The Significance of MMP-1 in EGFR-TKI-Resistant Lung Adenocarcinoma: Potential for Therapeutic Targeting. Int J Mol Sci. 2018 Feb 18;19(2). pii: E609. doi: 10.3390/ijms19020609.

5.Hayasaka K, Shiono S, Matsumura Y, Yanagawa N, Suzuki H, Abe J, Sagawa M, Sakurada A, Katahira M, Takahashi S, Endoh M, Okada Y. Epidermal growth factor receptor mutation as a risk factor for recurrence in lung adenocarcinoma. Ann Thorac Surg. 2018 Jun;105(6):1648-1654. doi: 10.1016/j.athoracsur.2018.01.052. Epub 2018 Feb 24.

6.Morita M, Sato T, Nomura M, Sakamoto Y, Inoue Y, Tanaka R, Ito S, Kurosawa K, Yamaguchi K, Sugiura Y, Takizaki H, Yamashita Y, Katakura R, Sato I, Kawai M, Okada Y, Watanabe H, Kondoh G, Matsumoto S, Kishimoto A, Obata M, Matsumoto M, Fukuhara T, Motohashi H, Suematsu M, Komatsu M, Nakayama KI, Watanabe T, Soga T, Shima H, Maemondo M, Tanuma N. PKM1 confers metabolic advantages and promotes cell-autonomous tumor cell growth. Cancer Cell. 2018 Mar 12;33(3):355-367.e7. doi: 10.1016/j.ccell.2018.02.004.

7.Ishibashi N, Watanabe T, Kanehira M, Watanabe Y, Hoshikawa Y, Notsuda H, Noda M, Sakurada A, Ohkouchi S, Kondo T, Okada Y. Bone marrow mesenchymal stromal cells protect allograft lung transplants from acute rejection via the PD-L1/IL-17A axis. Surg Today. 2018 Jul;48(7):726-734. doi: 10.1007/s00595-018-1643-x. Epub 2018 Mar 15.

8.Abe J, Okazaki T, Kikuchi N, Takahashi S, Sakurada A, Okada Y. Preoperative bronchoscopic cancer confirmation does not increase risk of recurrence in stage1A non-small cell lung cancer. Gen Thorac Cardiovasc Surg. 2018 May;66(5):284-290. doi: 10.1007/s11748-018-0909-y. Epub 2018 Mar 21.

9.Kikuchi M, Tanaka M, Takasaki S, Takahashi A, Akiba M, Matsuda Y, Noda M, Hisamichi K, Yamaguchi H, Okada Y, Mano N. Comparison of PETINIA and LC-MS/MS for determining plasma mycophenolic acid concentrations in Japanese lung transplant recipients. J Pharm Health Care Sci. 2018 Apr 2;4:7. doi: 10.1186/s40780-018-0101-7. eCollection 2018.

10.Kikuchi N, Satoh K, Kurosawa R, Yaoita N, Elias-Al-Mamun M, Siddique MAH, Omura J, Satoh T, Nogi M, Sunamura S, Miyata S, Saito Y, Hoshikawa Y, Okada Y, Shimokawa H. Selenoprotein P promotes the development of pulmonary arterial hypertension: a possible novel therapeutic target. Circulation. 2018 Aug 7;138(6):600-623. doi: 10.1161/CIRCULATIONAHA.117.033113.

11.Kulason K, Nouchi R, Hoshikawa Y, Noda M, Okada Y, Kawashima R. The beneficial effects of cognitive training with simple calculation and reading aloud (SCRA) in the elderly postoperative population: a pilot randomized controlled trial. Front Aging Neurosci. 2018 Mar 28;10:68. doi: 10.3389/fnagi.2018.00068. eCollection 2018.

12.Mitomo H, Sakurada A, Matsuda Y, Notsuda H, Watanabe T, Oishi H, Niikawa H, Maeda S, Noda M, Sado T, Amemiya T, Yoshida Y, Kikuchi T, Kamei K, Okada Y. Endobronchial topical amphotericin B instillation for pulmonary chromomycosis after lung transplantation: a case report. Transplant Proc. 2018 Apr;50(3):939-942. doi: 10.1016/j.transproceed.2017.12.028.

13.Yabuki H, Wakao S, Kushida Y, Dezawa M, Okada Y. Human multilineage-differentiating stress-enduring cells exert pleiotropic effects to ameliorate acute lung ischemia-reperfusion injury in a rat model. Cell Transplant. 2018 Jun;27(6):979-993. doi: 10.1177/0963689718761657. Epub 2018 Apr 30.

14.Tachibana K, Okada Y, Matsuda Y, Miyoshi K, Oto T, Chen-Yoshikawa TF, Date H, Minami M, Okumura M, Iwasaki A, Shiraishi T, Maeda S, Matsumura Y, Nakajima T, Yoshino I, Hayashi S. Nontuberculous mycobacterial and aspergillus infections among cadaveric lung transplant recipients in Japan. Respir Investig. 2018 May;56(3):243-248. doi: 10.1016/j.resinv.2017.12.010. Epub 2018 Feb 4.

15.Kamata S, Fujino N, Yamada M, Grime K, Suzuki S, Ota C, Tando Y, Okada Y, Sakurada A, Noda M, Matsuda Y, Sugiura H, Ichinose M. Expression of cytochrome P450 mRNAs in Type II alveolar cells from subjects with chronic obstructive pulmonary disease. Pharmacol Res Perspect. 2018 May 21;6(3):e00405. doi: 10.1002/prp2.405. eCollection 2018 Jun.

16.Aizawa H, Koarai A, Shishikura Y, Yanagisawa S, Yamaya M, Sugiura H, Numakura T, Yamada M, Ichikawa T, Fujino N, Noda M, Okada Y, Ichinose M. Oxidative stress enhances the expression of IL-33 in human airway epithelial cells. Respir Res. 2018 Jun 12;19(1):116. doi: 10.1186/s12931-018-0817-9.

17.Oishi H, Watanabe T, Matsuda Y, Noda M, Ejima Y, Saiki Y, Seyama K, Kondo T, Okada Y. Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan. Surg Today. 2018 Oct;48(10):951. doi: 10.1007/s00595-018-1682-3.

18.Onodera K, Sakurada A, Notsuda H, Watanabe T, Matsuda Y, Noda M, Endo C, Okada Y. Growth inhibition of KRAS and EGFR mutant lung adenocarcinoma by cosuppression of STAT3 and the SRC/ARHGAP35 axis. Oncol Rep. 2018 Sep;40(3):1761-1768. doi: 10.3892/or.2018.6536. Epub 2018 Jul 2.

19.Kobayashi K, Miki Y, Saito R, Adachi K, Seyama K, Okada Y, Sasano H. Roles of human epidermal growth factor receptor family in pulmonary lymphangioleiomyomatosis. Hum Hum Pathol. 2018 Nov;81:121-130. doi: 10.1016/j.humpath.2018.07.002. Epub 2018 Jul 18.

20.Okazaki T, Tamai K, Shibuya R, Nakamura M, Mochizuki M, Yamaguchi K, Abe J, Takahashi S, Sato I, Kudo A, Okada Y, Satoh K. Periostin is a negative prognostic factor and promotes cancer cell proliferation in non-small cell lung cancer. Oncotarget. 2018 Jul 27;9(58):31187-31199. doi: 10.18632/oncotarget.25435. eCollection 2018 Jul 27.

21.Sato K, Saiki Y, Arai K, Ishizawa K, Fukushige S, Aoki K, Abe J, Takahashi S, Sato I, Sakurada A, Okada Y, Horii A. S100A10 upregulation associates with poor prognosis in lung squamous cell carcinoma. Biochem Biophys Res Commun. 2018 Oct 28;505(2):466-470. doi: 10.1016/j.bbrc.2018.09.118. Epub 2018 Sep 27.

22.Suzuki H, Matsuda Y, Noda M, Oishi H, Watanabe T, Sado T, Yamada M, Tamada T, Okada Y. Management of De Novo Mycobacterial Infection After Lung Transplantation Without Rifampicin: Case Series of a Single Institution. Transplant Proc. 2018 Nov;50(9):2764-2767. doi: 10.1016/j.transproceed.2018.03.058. Epub 2018 Mar 15.

23.Matsuda Y, Eba S, Hoshi F, Oishi H, Sado T, Noda M, Sakurada A, Watanabe T, Niikawa H, Akiba M, Okada Y. Sustained-Release Tacrolimus Stabilizes Decline of Forced Expiratory Volume in 1 Second Through Decreasing Fluctuation of Its Trough Blood Level. Transplant Proc. 2018 Nov;50(9):2768-2770. doi: 10.1016/j.transproceed.2018.03.039. Epub 2018 Mar 16.

24.Yabuki H, Watanabe T, Oishi H, Katahira M, Kanehira M, Okada Y. Muse Cells and Ischemia-Reperfusion Lung Injury. Adv Exp Med Biol. 2018;1103:293-303. doi: 10.1007/978-4-431-56847-6_16.

25.Watanabe T, Hosaka T, Ohmori-Matsuda K, Suzuki Y, Suzuki H, Yabuki H, Matsuda Y, Noda M, Sakurada A, Okada Y, Sato Y. High preoperative plasma vasohibin-1 concentration predicts better prognosis in patients with non-small cell lung carcinoma. Health Sci Rep. 2018 May 17;1(6):e40. doi: 10.1002/hsr2.40. eCollection 2018 Jun.